Latest News for: Biotech startup

Edit

Global Pituitary Stalk Interruption Syndrome Treatment Market Set for Steady Growth Through 2035, Driven by Advances in Diagnostics and Hormone Therapies | FMI

Pharmiweb 29 May 2025
Big Pharma and Biotech Drive Innovation. The PSIS treatment landscape is highly competitive, involving both established pharmaceutical companies and agile biotech startups.
Edit

NanoViricides to Present at the BIO International Convention in Boston on Monday, June 16, 2025

ACCESSWIRE 28 May 2025
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profit organization, or government agency; or you work as a researcher, business development professional or ...
Edit

We can VAXit Bharat: Public sector alone can’t make India biotech-ready; firms, startups must jump in

The Times of India 27 May 2025
For that, existing biotech companies and new startups must abandon their risk aversion, and plunge into R&D.As with defence startups, the risk capital must come from both government and modest slices of our large retirement savings.
Edit

Archetype Therapeutics Announces Scientific Advisory Board

ACCESSWIRE 27 May 2025
He has co-founded several biotech companies, including Modifi Biosciences, a glioblastoma-focused startup acquired by Merck for $1.3 billion in upfront and milestone payments ... He serves on several biotech and academic advisory boards.
Edit

TNF-α in 2024: Rewriting the Rules of Inflammation and Immune Modulation

The Signal 27 May 2025
Several biotech startups, including AIpharm and Immunocircuit, are now applying machine learning models to predict TNF receptor binding, simulate immune cascade responses, and screen thousands of candidate molecules in silico.
Edit

Proteinase K Market to Reach USD 30.2 Million by 2025, Growing at 4.8% CAGR Through 2035

Pharmiweb 27 May 2025
... competing alongside innovative startups ... Additionally, emerging biotech firms and startups contribute fresh ideas and specialized products, often focusing on niche applications or novel formulations.
Edit

Is there life after extinction? Some scientists and conservationists are trying to find out

San Diego Union-Tribune 25 May 2025
... and conservationists interested in biotech and de-extinction ... Then last year, Colossal Biosciences, a biotech startup dedicated to de-extinction, tapped Shapiro to serve as their chief science officer.
Edit

This Biotech Startup Raised $34 Million For Urine-Based Tests To Help Diagnose Cancer

Forbes 23 May 2025
A grantee of the Gates Foundation, Hong Kong-based Phase Scientific built a business on the back of Covid-19 tests. Up next. using urine to compete with industry ‘gold standard’ HPV screening methods ... .
Edit

MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany

Knoxville Daily Sun 22 May 2025
HAMBURG, Germany, May 21, 2025 /PRNewswire/ -- MGI Tech Co., Ltd ... PrepALL ... The enhanced capabilities of the Smart 8 will cater to academic institutions, biotech startups, and clinical labs, offering a competitive edge in high-throughput research ... ....
Edit

State DMC Corp. board approves $8 million for development of shared lab space

Post Bulletin 22 May 2025
“You would create more than 16,000 square feet of specialized laboratory space to recruit dozens of biotech startups from Rochester and around the world, and these projects would generate more ...
Edit

74% of Korean bio firms struggle with financial difficulties: survey

Korea Times 21 May 2025
More than 7 out of 10 Korean biotech companies are facing financial difficulties, and nearly 4 in 10 have considered selling their business, a survey showed Wednesday ... the country's biotech ecosystem.
Edit

Liposomal Doxorubicin Market Set for Steady Growth with 6.3% CAGR Through 2034

Pharmiweb 21 May 2025
Partnerships between academic institutions, biotech startups, and pharmaceutical giants can drive innovation and accessibility ... Companies often form partnerships with research institutions and biotech ...
Edit

23andMe and its user data will soon belong to a pharmaceutical giant

The Verge 19 May 2025
New York-based biotech company Regeneron Pharmaceuticals announced an agreement on Monday to purchase the 23andMe startup for $256 million, alongside its Total Health and Research Services business and biobank of customer data and genetic samples.
×